Scientists investigate hidden link between immune disorders and brain health
NCT ID NCT06169150
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This study looks at how immune system diseases can cause problems in the brain and nerves, affecting movement, thinking, and feelings. Researchers will follow 350 people aged 2 and older with immune diseases, plus their healthy relatives, for up to 5 years. They will collect blood, spinal fluid, and other samples to better understand the connection and guide future treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 350 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2024
- Expected to finish
-
Oct 2043
An estimate. End dates often move.
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants will be recruited from NIH protocols 15-N-0125 (Natural History Study of Inflammatory and Infectious Diseases of the Nervous System) and 93-I-0119 (Detection and Characterization of Host Defense Defects), or from referrals. Biological relatives of affected participants may be enrolled on this study as controls.
- Ages
-
2 to 120 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Aged \>=2 years. To be seen at the NIH CC, participants must be \>=3 years of age. 2. Willing to allow specimens and data to be stored for future research. 3. Willing to allow genetic testing on their biospecimens. 4. Able to provide informed consent (for ages \>=18 years) or has parent(s) or guardian(s) who can provide permission to participate on their behalf (for ages \<18 years). * Decisionally impaired affected adult participants may have a legally authorized representative (LAR) to provide informed consent on their behalf. Additional Inclusion Criterion for Affected Participants: Has a primary or acquired immunodeficiency and known or suspected infection or inflammation of the nervous system or post-infection sequelae, based on clinical or imaging data provided by the referral facility, or is at risk of developing such a neurologic complication. For the purpose of this study, neuroinfectious disease or neuroinflammation is defined as any of the following: 1. Any neurologic symptoms accompanied by CSF with evidence of inflammation (which may include pleocytosis, hypoglycorrachia, elevated protein, or other evidence of intrathecal immune activation, including immunoglobulin \[Ig\] G index or presence of oligoclonal bands). 2. Systemic infection or inflammatory disease with neurologic involvement. 3. Neuroimaging suggestive of infection or inflammation (for example, presence of contrast-enhancing lesions on CT or MRI). 4. Clinical presentation suggestive of infection or inflammatory process of the nervous system without better explanation. 5. History of infection or inflammatory process of the nervous system. Affected participants must also have their own primary health care provider to manage their condition outside the NIH. Additional Inclusion Criteria for Biological Relatives and Healthy Volunteers: 1. Is either a biological relative of an affected participant or is unrelated. 2. Does not have a known diagnosis of neuroinfectious disease or neuroinflammation. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: 1. Pregnant (for biological relatives and healthy volunteers). 2. Any condition that, in the judgment of the investigator, may put the participant at undue risk or make them unsuitable for participation in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acquired immunodeficiency are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a PET tracer reveal hidden brain inflammation?
- Could everyday vitamins tame brain inflammation linked to obesity?
- Can a new pill tame psoriasis? early safety trial begins
- Could talk therapy boost brain function in schizophrenia?
- Wisdom tooth study probes brain chemicals for clues to pain and anxiety
- Herbal extract shows promise in calming schizophrenia